Propel Bio Management, LLC Portfolio Holdings

Propel Bio Management, LLC

  • $99.9 Billion
  • Q3 2025

Propel Bio Management, LLC has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $99.9 Billion distributed in 16 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Plains Gp Holdings LP with a value of $23.2B, Achieve Life Sciences Inc with a value of $11.9B, Akero Therapeutics, Inc. with a value of $10.9B, Milestone Pharmaceuticals Inc. with a value of $10.2B, and Applied Therapeutics Inc. with a value of $6.83B.

Examining the 13F form we can see an increase of $17.5B in the current position value, from $82.4B to 99.9B.

Propel Bio Management, LLC is based out at Los Angeles, CA

Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $99.9 Billion
Healthcare: $58.9 Billion
Energy: $23.2 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.47B
$23.2 Billion 23.23% of portfolio
1,272,360
Q3 2024 Reduced 7.29%
Achieve Life Sciences Inc
-
$11.9 Billion 11.94% of portfolio
-
Q3 2025 Reduced 38.46%
$2.52B
$10.9 Billion 10.88% of portfolio
228,884
Q1 2025 Reduced 33.41%
$61.8M
$10.2 Billion 10.26% of portfolio
5,124,890
Q3 2025 Added 186.06%
$10.6M
$6.83 Billion 6.83% of portfolio
11,285,420
Q1 2025 Added 17.37%
$575M
$6.51 Billion 6.51% of portfolio
552,927
Q3 2025 Reduced 40.09%
$26.5M
$5.14 Billion 5.15% of portfolio
974,022
Q2 2025 Added 56.09%
$76.8M
$4.71 Billion 4.72% of portfolio
438,509
Q3 2025 Added 93.99%
$1.2B
$4.01 Billion 4.01% of portfolio
155,000
Q3 2025 New
$21.6M
$3.52 Billion 3.52% of portfolio
1,932,304
Q3 2025 Reduced 7.42%
$363M
$2.92 Billion 2.93% of portfolio
510,000
Q3 2025 New
Nektar Therapeutics
-
$2.79 Billion 2.79% of portfolio
-
Q3 2025 New
Jasper Therapeutics Inc
-
$2.45 Billion 2.45% of portfolio
-
Q3 2025 New
$170M
$2.21 Billion 2.21% of portfolio
231,874
Q2 2025 Added 28.91%
$1.15B
$1.94 Billion 1.94% of portfolio
90,000
Q3 2025 New
Athira Pharma Inc
-
$618 Million 0.62% of portfolio
-
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 16
  • Current Value $99.9 Billion
  • Prior Value $82.4 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 12, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 6 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Propel Bio Management, LLC Portfolio

Follow Propel Bio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Propel Bio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Propel Bio Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email